| Type 1 MI | Type 2 MI | ||||
---|---|---|---|---|---|---|
Variable: N (%) or mean (SD)* | Lived | Died | P value | Lived | Died | P value |
N | 187 | 106 | Â | 139 | 164 | Â |
Age | 50 (9) | 52 (9) | 0.05 | 50 (11) | 48 (11) | 0.1 |
Female (%) | 32 (17) | 17 (16) | 0.8 | 35 (25) | 47 (29) | 0.5 |
Ethnicity | Â | Â | 0.2 | Â | Â | 0.2 |
 White | 102 (55) | 47 (44) |  | 35 (25) | 38 (23) |  |
 Black | 65 (35) | 50 (47) |  | 90 (65) | 115 (70) |  |
 Hispanic | 15 (8) | 5 (5) |  | 12 (9) | 6 (4) |  |
 Other/missing | 5 (3) | 4 (4) |  | 2 (1) | 5 (3) |  |
Log10(HIV viral load (VL) + 1) | 2.2 (1.4) | 2.8 (1.5) | 0.001 | 2.8 (1.6) | 3.3 (1.6) | 0.002 |
Log10(max VL + 1) | 4.8 (1.1) | 4.8 (1.2) | 0.9 | 4.8 (1.1) | 5.0 (1.1) | 0.04 |
CD4 | 472 (313) | 372 (276) | 0.005 | 361 (291) | 310 (291) | 0.1 |
Nadir CD4 | 186 (184) | 154 (154) | 0.1 | 185 (224) | 153 (179) | 0.2 |
BMI** | Â | Â | 0.005 | Â | Â | 0.002 |
 < 18.5 | 5 (3) | 8 (8) |  | 8 (6) | 23 (14) |  |
 18.5 to < 25 | 71 (38) | 40 (38) |  | 66 (47) | 72 (44) |  |
 25 to < 30 | 63 (34) | 37 (35) |  | 39 (28) | 25 (15) |  |
 ≥ 30 | 46 (25) | 14 (13) |  | 20 (14) | 25 (15) |  |
Missing BMI | 2 (1) | 7 (7) | Â | 6 (4) | 19 (12) | Â |
Diabetes | 44 (24) | 30 (28) | 0.4 | 31 (22) | 38 (23) | 0.9 |
eGFR < 30 mL/min/1.73m2 | 15 (8) | 18 (17) | 0.02 | 15 (11) | 36 (22) | 0.01 |
Statin use | 52 (28) | 32 (30) | 0.7 | 24 (17) | 17 (10) | 0.08 |
Treated hypertension | 63 (34) | 35 (33) | 0.9 | 52 (37) | 41 (25) | 0.02 |
Smoker | 93 (50) | 41 (39) | 0.07 | 61 (44) | 69 (42) | 0.8 |